Isosorbide mononitrate and Aricept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide mononitrate (isosorbide mononitrate) and Aricept (donepezil hydrochloride). Common drug interactions include electrocardiogram repolarisation abnormality among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide mononitrate and Aricept. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.



On Jul, 15, 2026

85 people who take Isosorbide mononitrate and Aricept together, and have interactions are studied.

Isosorbide mononitrate and Aricept drug interactions.

What are the common drug interactions of Isosorbide Mononitrate and Aricept, by gender? *:

female:

  1. Electrocardiogram repolarisation abnormality
  2. Headache (pain in head)
  3. Hypotension (abnormally low blood pressure)
  4. Long qt syndrome (disorder of the heart's electrical system)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nausea (feeling of having an urge to vomit)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)

male:

  1. Bradycardia (abnormally slow heart action)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  4. Hallucination (an experience involving the perception of something not present)
  5. Hypotension (abnormally low blood pressure)
  6. Nausea (feeling of having an urge to vomit)
  7. Pyrexia (fever)
  8. Sick sinus syndrome (a collection of heart rhythm disorders)
  9. Insomnia (sleeplessness)
  10. Arthralgia (joint pain)

What are the common drug interactions of Isosorbide Mononitrate and Aricept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Blood pressure decreased
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Dyspnoea (difficult or laboured respiration)
  5. Herpes zoster
  6. Infusion related reaction
  7. Injection site reaction

50-59:

  1. Abdominal discomfort
  2. Ear pain
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Vomiting

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypotension (abnormally low blood pressure)
  3. Insomnia (sleeplessness)
  4. Abdominal pain
  5. Acute hepatic failure
  6. Acute myocardial infarction (acute heart attack)
  7. Arthralgia (joint pain)
  8. Atrioventricular block first degree (heart block first degree)
  9. Blood pressure decreased
  10. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)

What are the existing conditions these people have? *

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 22 people, 25.88%
  2. High Blood Pressure: 16 people, 18.82%
  3. Pain: 10 people, 11.76%
  4. High Blood Cholesterol: 8 people, 9.41%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 9.41%
  6. Parkinson's Disease: 8 people, 9.41%
  7. Dementia (madness): 8 people, 9.41%
  8. Cardiac Disorder: 7 people, 8.24%
  9. Diabetes: 6 people, 7.06%
  10. Stress And Anxiety: 6 people, 7.06%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and Aricept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide mononitrate and Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aricept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate and donepezil hydrochloride (the active ingredients of Isosorbide mononitrate and Aricept, respectively), and Isosorbide mononitrate and Aricept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: